SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-11-000064
Filing Date
2011-10-31
Accepted
2011-10-31 16:34:17
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT pharmos10qq32011.htm 10-Q 390991
2 RULE 13A-14(A)/15D-14(A) CERTIFICATION ex311.htm EX-31.1 12312
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION ex312.htm EX-31.2 11252
4 SECTION 1350 CERTIFICATION ex321.htm EX-32.1 6722
5 SECTION 1350 CERTIFICATION ex322.htm EX-32.2 6398
  Complete submission text file 0001513160-11-000064.txt   1250826

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pars-20110930.xml EX-101.INS 110446
7 XBRL TAXONOMY EXTENSION SCHEMA pars-20110930.xsd EX-101.SCH 9818
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pars-20110930_cal.xml EX-101.CAL 20368
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pars-20110930_lab.xml EX-101.LAB 83286
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pars-20110930_pre.xml EX-101.PRE 53000
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 7324529556
PHARMOS CORP (Filer) CIK: 0000713275 (see all company filings)

IRS No.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-11550 | Film No.: 111168604
SIC: 2834 Pharmaceutical Preparations